Homocysteine and coronary heart disease risk in the PRIME study

Atherosclerosis

Volumn 191, Issue 1, 2007, Pages 90-97

  Troughton, J A ^a   Woodside, J V ^a   Young, I S ^a   Arveiler, D ^b   Amouyel, P ^c   Ferrieres J ^d   Ducimetiere P ^e   Patterson, C C ^a   Kee, F ^a   Yarnell, J W G ^a   Evans, A ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

^d INSERM   (France)

^e HÔPITAL PAUL BROUSSE   (France)

Author keywords

Coronary heart disease; Homocysteine; PRIME; Prospective cohort; Smoking

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; FRANCE; HUMAN; IRELAND; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; CORONARY DISEASE; FRANCE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; NORTHERN IRELAND; PROSPECTIVE STUDIES; RISK; SMOKING;

EID: 33846886735     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.014     Document Type: Article

References (41)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
2. Heller R.F., Chinn S., Pedoe H.D., and Rose G. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. Br Med J (Clin Res Ed) 288 (1984) 1409-1411
3. Yarnell J.W. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Prospective Epidemiological Study of Myocardial Infarction. QJM 91 (1998) 667-676
4. Scarabin P.Y., Arveiler D., Amouyel P., et al. Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study. Atherosclerosis 166 (2003) 103-109
5. Finkelstein J.D. Methionine metabolism in mammals. J Nutr Biochem 1 (1990) 228-237
6. Refsum H., Fiskerstrand T., Guttormsen A.B., and Ueland P.M. Assessment of homocysteine status. J Inherit Metab Dis 20 (1997) 286-294
7. Ueland P.M., Refsum H., Beresford S.A.A., and Vollset S.E. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 72 (2000) 324-332
8. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 (2002) 2015-2022
9. Ford E.S., Smith S.J., Stroup D.F., et al. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31 (2002) 59-70
10. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised, trials. Homocysteine Lowering Trialists' Collaboration. BMJ 316 (1998) 894-898
11. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325 (2002) 1202K-1206K
12. Rose G.A., Blackburn H., Gillum R.R., and Prineas R.J. Cardiovascular survey methods. 2nd ed. (1982), World Health Organisation, Geneva (Ref Type: Pamphlet)
13. Ducimetiere P., Ruidavets J.B., Montaye M., Haas B., and Yarnell J. Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50-59 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol 30 (2001) 1057-1062
14. Ubbink J.B., Hayward Vermaak W.J., and Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565 (1991) 441-446
15. Ubbink J.B., and Delport R. Homocysteine as atherothrombotic agent: is the bark worse than the bite?. Nutrition 16 (2000) 672-674
16. Chasan-Taber L., Selhub J., Rosenberg I.H., et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr 15 (1996) 136-143
17. Verhoef P., Hennekens C.H., Allen R.H., et al. Plasma total homocysteine and risk of angina pectoris with subsequent coronary artery bypass surgery. Am J Cardiol 79 (1997) 799-801
18. Folsom A.R., Nieto F.J., McGovern P.G., et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 98 (1998) 204-210
19. Fallon U.B., Ben Shlomo Y., Elwood P., Ubbink J.B., and Smith G.D. Homocysteine and coronary heart disease in the Caerphilly cohort: a 10 year follow up. Heart 85 (2001) 153-158
20. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277 (1997) 1775-1781
21. O'Callaghan P., Meleady R., Fitzgerald T., and Graham I. Smoking and plasma homocysteine. Eur Heart J 23 (2002) 1580-1586
22. Piyathilake C.J., Hine R.J., Dasanayake A.P., et al. Effect of smoking on folate levels in buccal mucosal cells. Int J Cancer 52 (1992) 566-569
23. Ortega R.M., Lopez-Sobaler A.M., Gonzalez-Gross M.M., et al. Influence of smoking on folate intake and blood folate concentrations in a group of elderly Spanish men. J Am Coll Nutr 13 (1994) 68-72
24. Weggemans R.M., de Groot L.C., and Haller J. Factors related to plasma folate and vitamin B12. The SENECA study. Int J Food Sci Nutr 48 (1997) 141-150
25. Cafolla A., Dragoni F., Girelli G., et al. Folate status in Italian blood donors: relation to gender and smoking. Haematologica 85 (2000) 694-698
26. Mansoor M.A., Kristensen O., Hervig T., et al. Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers. Clin Chem 43 (1997) 2192-2194
27. Subar A.F., Harlan L.C., and Mattson M.E. Food and nutrient intake differences between smokers and non-smokers in the US. Am J Public Health 80 (1990) 1323-1329
28. Fehily A.M., Phillips K.M., and Yarnell J.W. Diet, smoking, social class, and body mass index in the Caerphilly Heart Disease Study. Am J Clin Nutr 40 (1984) 827-833
29. Piyathilake C.J., Macaluso M., Hine R.J., Richards E.W., and Krumdieck C.L. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 60 (1994) 559-566
30. Dekou V., Gudnason V., Hawe E., et al. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemost 85 (2001) 67-74
31. Nygard O., Vollset S.E., Refsum H., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274 (1995) 1526-1533
32. Targher G., Bertolini L., Zenari L., et al. Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care 23 (2000) 524-528
33. Francis K.T., Thompson R.W., and Krumdieck C.L. Reaction of tetrahydrofolic acid with cyanate from urea solutions: formation of an inactive folate derivative. Am J Clin Nutr 30 (1977) 2028-2032
34. Abu K.M., Watkins C.L., and Krumdieck C.L. Inactivation of B12 and folate coenzymes by butyl nitrite as observed by NMR: implications on one-carbon transfer mechanism. Biochem Biophys Res Commun 135 (1986) 201-207
35. Frasca V., Riazzi B.S., and Matthews R.G. In vitro inactivation of methionine synthase by nitrous oxide. J Biol Chem 261 (1986) 15823-15826
36. Bergmark C., Mansoor M.A., Svardal A., and de Faire U. Redox status of plasma homocysteine and related aminothiols in smoking and nonsmoking young adults. Clin Chem 43 (1997) 1997-1999
37. De Bree A., Verschuren W.M., Blom H.J., and Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 y. Am J Clin Nutr 73 (2001) 1027-1033
38. Shimakawa T., Nieto F.J., Malinow M.R., et al. Vitamin intake: a possible determinant of plasma homocyst(e)ine among middle-aged adults. Ann Epidemiol 7 (1997) 285-293
39. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698
40. Bates C.J., Mansoor M.A., van der P.J., et al. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr 51 (1997) 691-697
41. Kyhse-Andersen J., Schmidt C., Nordin G., et al. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40 (1994) 1921-1926